SU607534A3 - Способ получени средств, обладающего фунгистатическим и фунгицидным дествием - Google Patents
Способ получени средств, обладающего фунгистатическим и фунгицидным дествиемInfo
- Publication number
- SU607534A3 SU607534A3 SU752172908A SU2172908A SU607534A3 SU 607534 A3 SU607534 A3 SU 607534A3 SU 752172908 A SU752172908 A SU 752172908A SU 2172908 A SU2172908 A SU 2172908A SU 607534 A3 SU607534 A3 SU 607534A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- fungicidic
- fungistasis
- effect
- substance possessing
- compositions
- Prior art date
Links
- 230000000694 effects Effects 0.000 title description 2
- 238000000034 method Methods 0.000 title description 2
- 239000000126 substance Substances 0.000 title 1
- XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 abstract description 4
- 229960004413 flucytosine Drugs 0.000 abstract description 4
- 230000000855 fungicidal effect Effects 0.000 abstract description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 2
- 230000001408 fungistatic effect Effects 0.000 abstract description 2
- 229930188428 trichomycin Natural products 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract 3
- YKSVGLFNJPQDJE-YDMQLZBCSA-N (19E,21E,23E,25E,27E,29E,31E)-33-[(2R,3S,4R,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-17-[7-(4-aminophenyl)-5-hydroxy-4-methyl-7-oxoheptan-2-yl]-1,3,5,7,37-pentahydroxy-18-methyl-9,13,15-trioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid Chemical compound CC(CC(C)C1OC(=O)CC(=O)CCCC(=O)CC(O)CC(O)CC(O)CC2(O)CC(O)C(C(CC(O[C@@H]3O[C@H](C)[C@@H](O)[C@@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C1C)O2)C(O)=O)C(O)CC(=O)C1=CC=C(N)C=C1 YKSVGLFNJPQDJE-YDMQLZBCSA-N 0.000 abstract 1
- 101000653791 Bos taurus Protein S100-A12 Proteins 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 206010046914 Vaginal infection Diseases 0.000 abstract 1
- 201000008100 Vaginitis Diseases 0.000 abstract 1
- 229960004348 candicidin Drugs 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 210000004379 membrane Anatomy 0.000 abstract 1
- 229960000988 nystatin Drugs 0.000 abstract 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 abstract 1
- 210000005000 reproductive tract Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000000003 vaginal tablet Substances 0.000 description 3
- 229940044977 vaginal tablet Drugs 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- -1 dimethyl methyl Chemical group 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000000624 ovulatory effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1279774 | 1974-09-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU607534A3 true SU607534A3 (ru) | 1978-05-15 |
Family
ID=4386491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU752172908A SU607534A3 (ru) | 1974-09-20 | 1975-09-19 | Способ получени средств, обладающего фунгистатическим и фунгицидным дествием |
Country Status (16)
| Country | Link |
|---|---|
| AT (1) | AT339471B (OSRAM) |
| AU (1) | AU476206B2 (OSRAM) |
| BE (1) | BE833589A (OSRAM) |
| CU (1) | CU34348A (OSRAM) |
| DD (1) | DD122023A5 (OSRAM) |
| DE (1) | DE2540799A1 (OSRAM) |
| FR (1) | FR2285133A1 (OSRAM) |
| GB (1) | GB1472046A (OSRAM) |
| HU (1) | HU172247B (OSRAM) |
| IE (1) | IE41720B1 (OSRAM) |
| IL (1) | IL48039A0 (OSRAM) |
| LU (1) | LU73422A1 (OSRAM) |
| NL (1) | NL7511001A (OSRAM) |
| SE (1) | SE7510429L (OSRAM) |
| SU (1) | SU607534A3 (OSRAM) |
| ZA (1) | ZA755632B (OSRAM) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2536492C2 (ru) * | 2008-08-01 | 2014-12-27 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | Применение 5-фторцитозина в качестве фунгицида |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010303832B2 (en) * | 2009-10-07 | 2015-02-12 | Dow Agrosciences Llc | Synergistic fungicidal composition containing 5-fluorocytosine for fungal control in cereals |
-
1975
- 1975-09-02 IL IL48039A patent/IL48039A0/xx unknown
- 1975-09-03 ZA ZA00755632A patent/ZA755632B/xx unknown
- 1975-09-04 AU AU84568/75A patent/AU476206B2/en not_active Expired
- 1975-09-12 DE DE19752540799 patent/DE2540799A1/de active Pending
- 1975-09-17 SE SE7510429A patent/SE7510429L/xx unknown
- 1975-09-18 FR FR7528601A patent/FR2285133A1/fr not_active Withdrawn
- 1975-09-18 NL NL7511001A patent/NL7511001A/xx not_active Application Discontinuation
- 1975-09-18 LU LU73422A patent/LU73422A1/xx unknown
- 1975-09-18 DD DD188429A patent/DD122023A5/xx unknown
- 1975-09-19 HU HU75HO00001836A patent/HU172247B/hu unknown
- 1975-09-19 IE IE2058/75A patent/IE41720B1/en unknown
- 1975-09-19 AT AT719775A patent/AT339471B/de not_active IP Right Cessation
- 1975-09-19 BE BE160174A patent/BE833589A/xx unknown
- 1975-09-19 GB GB3852875A patent/GB1472046A/en not_active Expired
- 1975-09-19 SU SU752172908A patent/SU607534A3/ru active
- 1975-09-20 CU CU7534348A patent/CU34348A/es unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2536492C2 (ru) * | 2008-08-01 | 2014-12-27 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | Применение 5-фторцитозина в качестве фунгицида |
Also Published As
| Publication number | Publication date |
|---|---|
| AU8456875A (en) | 1976-09-16 |
| IE41720B1 (en) | 1980-03-12 |
| HU172247B (hu) | 1978-07-28 |
| ATA719775A (de) | 1977-02-15 |
| AT339471B (de) | 1977-10-25 |
| IL48039A0 (en) | 1975-11-25 |
| LU73422A1 (OSRAM) | 1977-05-16 |
| GB1472046A (en) | 1977-04-27 |
| FR2285133A1 (fr) | 1976-04-16 |
| AU476206B2 (en) | 1976-09-16 |
| IE41720L (en) | 1976-03-20 |
| NL7511001A (nl) | 1976-03-23 |
| DD122023A5 (OSRAM) | 1976-09-12 |
| CU34348A (es) | 1979-09-08 |
| DE2540799A1 (de) | 1976-04-01 |
| SE7510429L (sv) | 1976-03-22 |
| BE833589A (fr) | 1976-03-19 |
| ZA755632B (en) | 1976-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BERGSTRÖM et al. | The prostaglandins: a family of biologically active lipids | |
| US3091569A (en) | Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus | |
| DK0501985T3 (da) | Uovertrukket farmaceutisk reaktionstablet | |
| CA2248179A1 (en) | .beta.-lactam antibiotic-containing tablet and production thereof | |
| US5573765A (en) | Composition and method for treatment of vaginal yeast infections | |
| US5340836A (en) | Composition and method for treatment of vaginal yeast infections | |
| DE59209706D1 (de) | S(+)-Ibuprofen enthaltende Arzneimittel | |
| DE58902457D1 (de) | Retardierte arzneiform und verfahren zu ihrer herstellung. | |
| ES546799A0 (es) | Procedimiento para la obtencion de formulaciones medicionales solidas de nitrendipina cristalina. | |
| AU2142988A (en) | Antiviral compounds | |
| GR3032800T3 (en) | Active substance complex for the production of biological parts, especially organs for living organisms; process for its production and its use. | |
| SU607534A3 (ru) | Способ получени средств, обладающего фунгистатическим и фунгицидным дествием | |
| IE43693L (en) | Androstane derivatives | |
| US4250169A (en) | Method of producing antibiotics suppositories | |
| IE791995L (en) | Formulation | |
| GB2000025A (en) | Nitroimidazole formulations | |
| JPS57146722A (en) | Pharmaceutical preparation having improved absorption | |
| US5118799A (en) | Process for converting crystalline erythromycin ethylsuccinate into stable amorphous erythromycin ethylsuccinate | |
| ES469749A1 (es) | Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol. | |
| ES475660A1 (es) | Un procedimiento para la preparacion de un tiol acido y sus sales y esteres | |
| DE3887201T2 (de) | Erythromycin-Derivate und ihre Herstellung und Verwendung. | |
| GB1292496A (en) | Dosage units of contraceptive preparations for human use | |
| NL7810163A (nl) | Arylalkylalkaancarbonzuren, geneesmiddel met als werk- zaam bestanddeel alkaancarbonzuur en werkwijze voor de bereiding van de arylalkylalkaancarbonzuren. | |
| CA2022323A1 (en) | Excretion of potassium ion by prostanoic acid derivatives | |
| IE43582L (en) | Desoxystreptamine derivatives |